Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer
Winter 2021/2022

Ask a Clinician: What Is the Difference Between Physical and Occupational Therapies?

Healthe's clinicians tackle common workers' comp questions
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Rezenopy Approved for Treatment of Opioid Overdose

A new naloxone nasal spray will soon be available.
May 2024

Triple Threat: Healthcare Fraud, Waste and Abuse in Workers’ Comp

Identifying and combating a multifaceted problem, including proven and developing strategies.
May 2024

WCRI Publishes 24th Edition of CompScope Benchmarks

A total of 14 different reports examine workers’ comp system performance across 17 states from 2017-2022.
May 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020

Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020
1 13 14 15 16 17 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle